Clinical Trials Logo

Pruritus clinical trials

View clinical trials related to Pruritus.

Filter by:

NCT ID: NCT02828787 Terminated - Itch Clinical Trials

Central Mechanisms of Chronic Pruritus: Functional and Structural Brain Imaging.

PRURIM
Start date: January 16, 2017
Phase: N/A
Study type: Interventional

The main objective of this study is to identify by functional and structural MRI which are the brain areas activated in various pruritic situations to deduct a model describing the different causes of pruritus. The investigators are going to compare two chronic pruritus conditions (histaminergic urticaria and non histaminergic: psoriasis) to a healthy control group. The secondary objective of this study is to specify a classification index from the physiological results obtained by brain imaging to differentiate multiple types of pruritus.

NCT ID: NCT02823067 Completed - Pruritus Clinical Trials

Pruritus and Pemphigoid in Nursing Home Patients

SSENIOR
Start date: June 1, 2016
Phase:
Study type: Observational

The primary objective of this observational study is to describe the prevalence of pruritus and pemphigoid in nursing home patients. Secondary outcomes are the relationships of demographic factors and medical risk factors with pemphigoid, including dementia and neuropsychiatric symptoms, medication use and Karnofsky score.

NCT ID: NCT02811783 Terminated - Mycosis Fungoides Clinical Trials

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Start date: January 2017
Phase: Phase 3
Study type: Interventional

This multi-center, double-blind, vehicle-controlled, randomized crossover design study will evaluate the safety and efficacy of topically applied naloxone lotion, 0.5%, for the treatment of pruritus in patients with the mycosis fungoides (MF) or Sézary syndrome (SS) Forms of Cutaneous T-cell Lymphoma (CTCL). This study will also determine if there is systemic absorption of the drug in a subset of subjects and if so, describe the range and mean plasma levels reached after two weeks of three time daily (TID) dosing. Funding Source - FDA OOPD

NCT ID: NCT02793843 Completed - Cesarean Section Clinical Trials

Ondansetron vs Ondansetron Plus Dexamethasone for Relieving Intrathecal Morphine Side Effects After C-section

Start date: June 2016
Phase: N/A
Study type: Interventional

Background: Common adverse side effects related to the use of neuraxial opioids in the obstetric population include nausea, vomiting, and pruritus. Serotonin (5-HT3) receptor antagonists, in particular ondansetron, have been identified as possible antipruritic agents. It was reported that dexamethasone plus ondansetron is more effective than ondansetron for prevention of postoperative nausea and vomiting but no additional effect on treating pruritus. Objectives: The purpose of this study is to compare the effect of prophylactic ondansetron versus ondansetron plus dexamethasone after cesarean section on pruritus and postoperative nausea and vomiting (PONV). Methods: A prospective randomized double blind study that will be conducted between June 2016 and June 2017. Patients will be randomly allocated into two groups. The first group will receive 4 mg intravenous (IV) ondansetron while the other group will receive 4 mg IV ondansetron plus 8 mg dexamethasone.

NCT ID: NCT02769910 Completed - Pruritus Clinical Trials

Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch

Start date: May 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this project is to investigate the effect of capsaicin-induced neurogenic inflammation with three different intensities on itch subsequently induced by histamine and cowhage. The hypothesis is that capsaicin-induced pre-established neurogenic inflammation significantly increases susceptibility to itch provocations with cowhage and histamine.

NCT ID: NCT02747979 Completed - Insomnia Clinical Trials

The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia Patients

Start date: April 2009
Phase: Phase 2/Phase 3
Study type: Interventional

A prospective, randomized, controlled open clinic trial to evaluate the effect and safety of combination of conventional hemodialysis(HD) and hemoperfusion(HP) on middle molecules removal and complications improvement in long-term maintenance hemodialysis (MHD) patients. There are two phases of study for each subject. Phase 1 (screening phase). During this phase, each potential subject will be evaluated to determine if he/she is eligible for the study. Phase 2 (intervention phase). Each subject will be randomly allocated to HD+HP(HA130 once per week) group ,HD+HP(HA330 once per week) group and HD group. The follow-up duration was 3 months.

NCT ID: NCT02696499 Completed - Uremic Pruritus Clinical Trials

Treatment of Uremic Pruritus With PA101B

Start date: February 2016
Phase: Phase 2
Study type: Interventional

This is a randomized, double blind, placebo-controlled, parallel-arm, multi-center, Phase 2, proof-of-concept efficacy and safety study in patients with end-stage renal disease requiring hemodialysis. The purpose of the study is to determine the efficacy and safety profile of PA101B delivered via eFlow high efficiency nebulizer in patients with uremic pruritus who are symptomatic despite using standard treatments.

NCT ID: NCT02691507 Completed - Atopic Dermatitis Clinical Trials

Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema

Start date: February 2016
Phase: Phase 2
Study type: Interventional

The objective of this 1 week trial is to evaluate the efficacy of an over-the-counter (OTC) 1% colloidal oatmeal skin protectant cream in adults and children with mild to moderate AD.

NCT ID: NCT02672579 Completed - Chronic Pruritus Clinical Trials

Study of Kids Itch Severity (SKIS)

SKIS
Start date: May 2015
Phase:
Study type: Observational

This purpose of this study is to validate two measures of chronic itching in kids: itch severity (ItchyQuant) and the impact on their quality of life (ItchyQoL).

NCT ID: NCT02671162 Completed - Clinical trials for End-Stage Renal Disease

Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus

Start date: July 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Fumaria Parviflora L. can minimize severity of pruritus in patients with end-stage renal disease.